Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:40 PM
Ignite Modification Date:
2025-12-24 @ 5:40 PM
NCT ID:
NCT00940368
Eligibility Criteria:
Inclusion Criteria:
* All patients must have a histologically confirmed diagnosis of Osteosarcoma/ Malignant Fibrohistiocytoma of bone that is currently being treated with chemotherapy with high emetogenic potential chemotherapeutic agent(Cisplatin at a dose 120mg/m2 ; Adriamycin 75 mg/m2)
* Age group : 8-21 yrs.
* Weight : greater than or equal to 20 kg and less than 40 kg in Category 1
* Weight : greater than or equal to 40 kg and less than 60 kg in Category 2
* Patients who are willing to participate in study.
* Patients or their parents who can understand Hindi or English.
Exclusion Criteria:
* Patients of age \<8 yrs or age \>21 yrs.
* Weight \< 20 kg and greater than or equal to 40 kg in Category 1
* Weight \< 40 kg and greater than or equal to 60 kg in Category 2
* Patients receiving chemotherapy with drugs other than Cisplatin.
* Patients receiving a dosage of chemotherapy with Cisplatin\<120 mg/m2.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
8 Years
Maximum Age:
21 Years
Study:
NCT00940368
Study Brief:
Protocol Section:
NCT00940368